Laura Eve Schanberg
Professor of Pediatrics

I am involved in both hypothesis driven clinical research as well as clinical trials, both of which are described below. 

My research team consists of health psychologists, medical fellows, and graduate students in clinical psychology. Most broadly, the research team has interests in studying stress and coping processes in children with chronic disease and their families. Particular interests include describing the pain experience of children with chronic arthritis and the role of parental processes in child adjustment to chronic disease. 

We continue to investigate the daily pain of children with arthritis in real time and their responses to pain, including activity and school function, as well as emotional regulation. In addition, we are examining the responses of parents to their child's pain in real time recorded using an electronic device.

I am also active in the several clinic trials in pediatric rheumatology. I was the Principal Investigator for an NIH funded 21 center interventional trial entitled Prevention of Cardiovascular Complications of SLE: Atherosclerosis Prevention in Pediatric Lupus (APPLE) in conjunction with the Duke Clinical Research Institute (DCRI) and the Childhood Arthritis and Rheumatology Research Association (CARRA). This trial enrolled 221 children and adolescents with SLE and studied the efficacy and safety of statin therapy in children with SLE. The results have been published. Currently I am leading several clinical research efforts including both industry and investigator initiated clinical trials. 

I am actively engaged with the CARRA network strengthening and broadening research infrastructure to make more pediatric rheumatology sites able to participate in clinical research, including testing consensus treatment plans developed by CARRA members for pediatric rheumatic diseases and a national registry of rheumatic disease to study medication safety and comparative effectiveness. This effort was jump started by a grant from the NIH as part of the American Recovery Act but is now supported by industry and the Arthritis Foundation. The CARRA registry includes 60 CARRA sites and has enrolled 1700 children with JIA since reopening in July 2015.  From this information, we hope to learn more about the outcomes of childhood rheumatic disease and establish best treatment practices. The CARRA Registry will be adding SLE in 2017 as well as several other pediatric rheumatic diseases. 


Current Appointments and Affiliations

Contact Information

  • Box 3212 Med Ctr, Durham, NC 27710
  • T0909, Durham, NC 27710

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.